Skip to main content

Walleye Capital LLC

Position in APLS — Apellis Pharmaceuticals, Inc.

CIK 1758720 NEW YORK, NY

Position in APLS

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$0
+$0 QoQ
Shares Held
3,290
-16.8% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in APLS Over Time

Shares Held

Position Value (USD)

Derivatives in APLS

reported options exposure · as of Mar 31, 2026
CallValue
$0
CallShares
40,200
PutValue
$0
PutShares
3,200

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Walleye Capital LLC holds $328,656,270 across 126 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in APLS

Export CSV
46 filing rows on record
Report Date Value (USD) Shares
2026-03-31 3,200
2026-03-31 40,200
2026-03-31 3,290
2025-12-31 4,800
2025-12-31 7,500
2025-12-31 3,955
2025-09-30 12,800
2025-09-30 142,158
2025-09-30 4,600
2025-06-30 81,270
2025-06-30 19,900
2025-06-30 7,500
2025-03-31 500
2025-03-31 9,500
2025-03-31 317,442
2024-12-31 394,823
2024-12-31 2,800
2024-12-31 4,800
2024-09-30 102,080
2024-09-30 200
2024-06-30 12,800
2024-06-30 50,639
2024-06-30 1,800
2024-03-31 55,900
2024-03-31 110,799
2024-03-31 27,200
2023-12-31 10,000
2023-12-31 147,674
2023-12-31 17,200
2023-09-30 40,700
2023-09-30 17,300
2023-09-30 133,983
2023-06-30 57,909
2023-06-30 8,400
2023-06-30 13,500
2023-03-31 2,300
2023-03-31 6,100
2023-03-31 119,378
2022-12-31 9,100
2022-12-31 18,300
2022-09-30 1,300
2022-09-30 14,700
2022-03-31 12,687
2021-12-31 115,133
2020-03-31 14,600
2020-03-31 9,500